Jonathan Jackson's LLY trades
- The latest LLY trade was a sale on Jun 3, 2025, when LLY closed at $750.78. It closed at $1416.96 on Nov 3, 2026 (+89%).
Price changes use the closing price on each trade date, not the price actually paid, and ignore dividends. Filings report amounts only as ranges, so these figures show direction, not anyone's actual profit.
Jonathan Jackson reported 4 LLY transactions in 3 filings with the House Clerk for 2025–2026: 2 purchases and 2 sales of Eli Lilly and Company, with trade dates from Apr 21, 2025 to Jun 3, 2025. The median gap between trade date and filing date is 69 days, and 2 trades were reported more than 45 days after it happened.
- 4
- 2 / 2
- $32K – $130K
- 2025-08-25
LLY transactions reported by Jonathan Jackson
| Type | Owner | ||||
|---|---|---|---|---|---|
Eli Lilly and Company Common Stock LLY | Sale | Joint | $15,001 - $50,000 | 2025-07-14 #20030599 | |
Eli Lilly and Company Common Stock LLY | Sale | Spouse | $1,001 - $15,000 | 2025-08-25 #20030860 | |
Eli Lilly and Company Common Stock LLY | Purchase | Spouse | $1,001 - $15,000 | 2025-08-25 #20030860 | |
Eli Lilly and Company Common Stock LLY | Purchase | Joint | $15,001 - $50,000 | 2025-05-13 #20030283 |
A row is a disclosure, not an execution record: the filing reports a date, a bracket, and the reported owner, but not the price, share count, or reason. Compare the trade date with the filing date to see how long the transaction stayed private.
How long disclosure took
Days from trade date to filing date for 4 rows. The STOCK Act allows 30 days from notification and no more than 45 days from the trade. A late row is a timing fact, not evidence of wrongdoing.
- 0–15 days
- 0
- 16–30 days
- 1
- 31–45 days
- 1
- Over 45 days
- 2
- Median / longest
- 69d / 124d
What Jonathan Jackson's LLY filings don’t tell you
A disclosure row records a trade date, an amount bracket, and who owned the asset. It does not say why the trade was made, whether the position is still held, or anything about the business behind the ticker: revenue trends, margins, balance-sheet risk, or valuation. Those answers are in company filings, not congressional ones.
- Eli Lilly and Company financials and filings
Audited SEC figures, what moves LLY, and primary sources.
Compare ABBV vs LLY side by side
To work through a company yourself, use our stock research checklist. Members get the full version of that work: one sourced investment call a month, with the numbers and the risks that would change the view.
Members-only research
What members are reading this month
- NVIDIA’s growth has a financing bill
Sales up about 18% on the prior quarter, receivables up about 55%, supply commitments at $279 billion. What NVIDIA’s financing bill means for the price you pay.
- Citadel bought the AI fire sale. The seller had run out of time.
Up 439% in the first half, down about 67% in July: how an AI hedge fund ended up selling a roughly $16 billion stock book to Citadel at a discount.
The thesis, the numbers behind it, and what would break it. Full access is $39 a month.
Read the full researchOther members of Congress who reported LLY
More tickers reported by Jonathan Jackson
Jonathan Jackson and LLY: questions
Did Jonathan Jackson buy or sell LLY?
House Clerk filings for 2025 and 2026 show 2 purchases and 2 sales of Eli Lilly and Company (LLY) reported by Jonathan Jackson, between 2025-04-21 and 2025-06-03. Reported owners: Joint, Spouse.
How much LLY did Jonathan Jackson trade?
Filings disclose brackets, not exact values. Summing the low and high ends of each bracket gives $32K – $130K across 4 transactions. Yield Theory does not estimate share counts, prices, or gains from these ranges.
When was the last LLY filing by Jonathan Jackson?
The most recent filing that includes a LLY trade was filed on 2025-08-25. New filings appear in the House Clerk index and are picked up when the dataset is refreshed.
Yield Theory is not affiliated with any elected official or with Eli Lilly and Company. Rows are parsed from public House Clerk periodic transaction reports; amounts are reported brackets and filings can be amended. This page is educational and is not investment advice.
Don’t copy the filing. Read the thesis.
Jonathan Jackson LLY disclosures are delayed, ranged, and often a spouse. Members get the monthly call that treats those rows as one input, then names catalysts, risks, and what would change the view. $39/month or $249/year.
Members-only research
$39/mo or $249/yr · cancel future renewals anytime · sources included